Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7424

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 0904-7424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lurasidone-120mg-30s-count-label (Lurasidone 120mg 30s Count Label)

Label for lurasidone hydrochloride tablets 120 mg by Major Pharmaceuticals. The label states the dosage form as film-coated tablets, with a package count of 30 tablets. It includes storage instructions, manufacturer MSN Pharmaceuticals Inc., and distributor Major Pharmaceuticals. The label also features the NDC number 0904-7425-46 and a barcode.*

FDA Label Image

Lurasidone-20mg-30s-count-label (Lurasidone 20mg 30s Count Label)

Label for Lurasidone Hydrochloride Tablets 20 mg by Major Pharmaceuticals. The label shows the product name, strength (20 mg), dosage form (tablets), quantity (30 tablets), prescription status (Rx only), storage instructions, and manufacturer information as MSN Pharmaceuticals Inc., Piscataway, NJ. A barcode and references to the medication guide and usual dosage directions are included.*

FDA Label Image

Lurasidone-40mg-30s-count-label (Lurasidone 40mg 30s Count Label)

Label for Lurasidone Hydrochloride Tablets 40 mg, film-coated oral tablets from Major Pharmaceuticals. The label includes the NDC 0904-7422-46, a package count of 30 tablets, and states storage instructions and warnings. The label also identifies the manufacturer as MSN Pharmaceuticals Inc. and the distributor as Major Pharmaceuticals, with website information provided.*

FDA Label Image

Lurasidone-60mg-30s-count-label (Lurasidone 60mg 30s Count Label)

Lurasidone Hydrochloride Tablets 60 mg film-coated oral tablets label from Major Pharmaceuticals. The label indicates the package contains 30 tablets, is for prescription use only, and includes storage instructions at 20 to 25°C. The product is manufactured by MSN Pharmaceuticals Inc. and distributed by Major Pharmaceuticals, with NDC 0904-7423-46 visible alongside barcodes.*

FDA Label Image

Lurasidone-80mg-30s-count-label (Lurasidone 80mg 30s Count Label)

Label for Lurasidone Hydrochloride Tablets 80 mg film-coated tablets by Major Pharmaceuticals. The label indicates a 30-tablet count with prescription only status. It includes storage instructions, medication guide information, and manufacturer details (MSN Pharmaceuticals Inc., Piscataway, NJ). Two barcodes and the National Drug Code (NDC 0904-7424-46) are visible.*

FDA Label Image

Lurasidone-figure-01 (Lurasidone Figure 01)

A pharmacokinetic impact chart showing the fold change and 90% confidence intervals for various interacting drugs on lurasidone pharmacokinetics (Cmax and AUC). It includes strong and moderate CYP3A4 inhibitors and inducers such as ketoconazole, diltiazem, rifampin, and lithium, plotted as changes relative to lurasidone alone on a horizontal axis ranging from -4 to 4.*

FDA Label Image

Lurasidone-figure-02 (Lurasidone Figure 02)

A forest plot chart showing pharmacokinetic data comparing several interacting drugs with lurasidone hydrochloride taken alone. The chart displays fold change and 90% confidence intervals for Cmax and AUC parameters for various drugs, including p-gp substrates, digoxin, midazolam, oral contraceptives (ethinyl estradiol and norelgestromin), and lithium, along with dosing information and adjustment recommendations.*

FDA Label Image

Lurasidone-figure-03 (Lurasidone Figure 03)

A pharmacokinetic chart labeled 'Fold Change and 90% CI' showing the effects of renal and hepatic impairment and population demographics (gender, race, Asian) on pharmacokinetic parameters Cmax and AUC for lurasidone hydrochloride. The x-axis represents change relative to reference, ranging from 0 to 6, with plotted points and confidence intervals for mild, moderate, and severe impairment categories, alongside dosage recommendations for each impairment level.*

FDA Label Image

Lurasidone-structure (Lurasidone Structure)

Chemical structure of lurasidone hydrochloride showing its molecular framework with labeled atoms and bonds representing the active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.